[1]刘文佳,刘宗凯,初晓苏,等.基于网络药理学探讨青蒿鳖甲汤及补中益气汤治疗癌性发热的“同病异治”分子作用机制[J].西部中医药,2023,36(07):20-26.[doi:10.12174/j.issn.2096-9600.2023.07.05]
 LIU Wenjia,LIU Zongkai,CHU Xiaosu,et al.Network Pharmacology-based Discussion on Molecular Mechanism of "Different Treatment of the Same Disease" in the Treatment of Cancerous Fever by Qinghao Bijia Tang and Buzhong Yiqi Tang[J].Western Journal of Traditional Chinese Medicine,2023,36(07):20-26.[doi:10.12174/j.issn.2096-9600.2023.07.05]
点击复制

基于网络药理学探讨青蒿鳖甲汤及补中益气汤治疗癌性发热的“同病异治”分子作用机制
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年07期
页码:
20-26
栏目:
出版日期:
2023-07-15

文章信息/Info

Title:
Network Pharmacology-based Discussion on Molecular Mechanism of "Different Treatment of the Same Disease" in the Treatment of Cancerous Fever by Qinghao Bijia Tang and Buzhong Yiqi Tang
作者:
刘文佳1, 刘宗凯1, 初晓苏2, 刘寨东1
1.山东中医药大学附属医院,山东 济南 250035
2.山东中医药大学,山东 济南 250035
Author(s):
LIU Wenjia1, LIU Zongkai1, CHU Xiaosu2, LIU Zhaidong1
1.Affiliated Hospital to Shandong University of Traditional Chinese Medicine, Jinan 250035, China
2.Shandong University of Traditional Chinese Medicine, Jinan 250035, China
关键词:
癌性发热同病异治青蒿鳖甲汤补中益气汤网络药理学中医中药
Keywords:
cancerous feverdifferent treatment of the same diseasenetwork pharmacologyTCM
分类号:
R966
DOI:
10.12174/j.issn.2096-9600.2023.07.05
文献标志码:
A
摘要:
目的通过网络药理学原理探讨青蒿鳖甲汤及补中益气汤治疗癌性发热的“同病异治”潜在作用机制。 方法在中药系统药理学数据库平台检索青蒿鳖甲汤及补中益气汤的活性成分并预测其潜在靶点,借助Cytoscape 3.7.2软件构建药物成分与靶点之间的网络图;通过疾病相关数据库平台检索癌性发热的疾病靶点,利用Venny在线工具构建药物与疾病的关键靶点Venny图。基于STRING数据库构建PPI网络图,然后按dgree值进一步筛选核心靶点;运用DAVID数据库实现对于基因本体、京都基因及基因组百科全书通路富集的分析。 结果经过筛选得到青蒿鳖甲汤有效活性成分45个,潜在作用靶点140个;补中益气汤有效活性成分163个,潜在作用靶点127个。经疾病数据库获得癌性发热相关靶基因3440个,3组靶点映射出关键靶点102个,根据dgree≥44筛选到13个核心靶点。富集出141个生物过程及47条信号通路。 结论青蒿鳖甲汤与补中益气汤治疗癌性发热主要与正向调控一氧化氮生物合成、DNA转录、酶结合、平滑肌细胞增殖等141个生物过程有关。通过肿瘤坏死因子、丝裂原活化蛋白激酶、NOD样受体、TOLL样受体、叉头转录因子等特异性通路调控癌症患者炎症水平,改善发热症状。
Abstract:
ObjectiveTo explore the potential mechanism of "different treatment of the same disease" in the treatment of cancerous fever by Qinghao Bijia Tang and Buzhong Yiqi Tang through network pharmacology. MethodsThe active ingredients of Qinghao Bijia Tang and Buzhong Yiqi Tang were searched from TCMSP, to predict the potential targets, the network plot between the drug components and the target sites were constructed via Cytoscape 3.7.2 software; disease targets of cancerous fever were retrieved from disease-related database platform, Venny diagram of key targets of disease and drugs were built using Venny online tool. PPI network diagram between proteins were constructed based on STRING database, and then the core targets were further screened according to Dgree value; GO and KEGG analysis were realized using DAVID database. ResultsBy screening, there were 45 active ingredients in Qinghao Biejia Tang, and 140 potential targets; 163 active ingredients in Buzhong Yiqi Tang and 127 potential targets. All 3440 target genes related to cancerous fever were obtained through the disease database, three groups of targets mapped out of 102 key targets, and 13 core targets were screened according to Degree≥44. All 141 biological processes and 47 signal pathways were enriched. ConclusionThe treatment of cancerous fever with Qinghao Bijia Tang and Buzhong Yiqi Tang is mainly related to 141 biological processes such as positive regulation of nitric oxide biosynthesis, DNA transcription, enzyme binding, and smooth muscle cell proliferation. The therapy could adjust the patients’ inflammation level and improve fever symptoms through specific pathways including TNF signal pathway, MAPK signal pathway, NOD-like receptor signal pathway, TOLL-like receptor signal pathway, and FOXO signal pathway.

相似文献/References:

[1]张竹君,王煜.王自立主任医师治疗不寐验案举隅[J].西部中医药,2014,27(04):26.
 ZHANG Zhujun,WANG Yu.Examples of Chief Physician Wang Zili′s Experience of Treating Insomnia[J].Western Journal of Traditional Chinese Medicine,2014,27(07):26.
[2]王煜,田苗.王自立主任医师治疗口疮验案举隅[J].西部中医药,2014,27(08):19.
[3]王煜,赵统秀.王自立主任医师治疗胃脘痛验案举隅[J].西部中医药,2014,27(11):50.
[4]王煜,赵统秀,芦少敏△.王自立主任医师治疗泄泻验案举隅[J].西部中医药,2014,27(12):28.

备注/Memo

备注/Memo:
刘文佳(1984—),女,硕士学位,主治医师。研究方向:肿瘤疾病的中西医结合治疗。△;刘寨东(1974—),男,博士学位,主任医师。研究方向:肿瘤疾病的中西医结合治疗。山东省自然科学基金(ZR2014HL063,ZR2016HL50)。
更新日期/Last Update: 2023-07-15